_____________________________________________________________________
Nanotechnology is the manipulation or selfassembly of individual atoms, molecules, or molecular clusters into structures to create materials and devices with new or vastly different properties. Nanotechnology can work from the top down (which means reducing the size to the nanoscale e.g. marble block to a statue or the bottom up (which involves manipulating individual atoms and molecules into nanostructures ie. we add matter till we end with the final or the desired product. Nanotechnology has been described as the new industrial revolution and both developed and developing countries are investing heavily in this technology to secure a market share.
The economy of the future will be a "knowledge-based economy" and maximizing knowledge through education, research and innovation will be important goals. Nanotechnology has a vast potential to revolutionize the critical sectors of the economy viz. health and agriculture: the subjects chosen for this talk. New tools for the treatment of diseases, disease detection, smart sensors and smart delivery systems for both mankind and agriculture are being developed and it will help to combat the viruses and other pathogens that effect both humans and the agriculture sector. It is expected that In the near future it will become possible through nanotechnology to increase the efficiency of drugs and pesticides and yet using lower doses. In the recent years applications of nanoscale biotechnology to food systems have been identified and are being pursued. Some of the studies are directed towards developing nano-sensing technology for detecting trace components in food, preserving food nutrients for an extended term and developing technology for preserving functional components without negatively impacting the palatability of food. _____________________________________________________________________ Nanotechnology is the manipulation or selfassembly of individual atoms, molecules, or molecular clusters into structures to create materials and devices with new or vastly different properties. Nanotechnology can work from the top down (which means reducing the size to the nanoscale e.g. marble block to a statue or the bottom up (which involves manipulating individual atoms and molecules into nanostructures ie. we add matter till we end with the final or the desired product. Nanotechnology has been described as the new industrial revolution and both developed and developing countries are investing heavily in this technology to secure a market share.
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Introduction:
Autologous Immune Enhancement therapy (AIET) is one of the lesser used modality of therapy in our country for advanced cancers. AIET uses patient's own immune cells such as NK cells and T-Lymphocytes to fight against cancer.
Aim:
To study the effectiveness of AIET in Advanced Carcinoma of pancreas.
Case History:
A 40 years old male was diagnosed with inoperable locally advanced Carcinoma of the head of pancreas when he was investigated for obstructive jaundice. Palliative bypass surgery was done, since his tumor was inoperable. Following his surgery he received 6 cycles of adjuvant chemotherapy and 3 cycles of AIET. After completion of chemotherapy and 2 cycles of AIET therapy his tumor marker decreased significantly with decrease in tumor size. So re-laparotomy was attempted for removal of tumor, which was unsuccessful. After a long gap he received his 3rd cycle of AIET. He was irregular in receiving his AIET treatment. He survived for 18 months after the diagnosis.
Conclusion:
The median life span of patients following diagnosis of advanced Carcinoma of pancreas is usually not more than 3-6 months. Longer survival of our patient could be due to AIET, but we need further studies to prove it. There were no adverse effects encountered due to AIET. 
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Background:
Stem Cell Therapy (SCT) although in vogue since the early seventies for Hematological malignancies, is slowly evolving and extending into other fields. In Spinal Cord Injury its indications and uses are still getting refined.
Materials and methods:
In our centre, after extensive review of literature drew up our own inclusion/ exclusion criteria which was approved by our ethics committee. We selected six patients with Dorsal Spinal Cord Injury for this study. Epidemiological and clinical data was collected and Videography of the patient's initial presentation was done. Clinical assessment was carried out by a team of specialist including the Neurosurgeon, Neurologist, Urologist and Physiotherapist.100 ml of Bone marrow harvested from the posterior iliac crest was sent in cold preservation to NCRM, Chennai. Bone Marrow Mono Nuclear cells were isolated and CD34+ cells quantified using FACS. The isolated cells were injected through lumbar puncture. One of the six patients received two sittings of SCT, while all others have undergone only one sitting. The patients were followed on a monthly basis during which regular neurological reassessment was done and domiciliary physiotherapy was also given.
Result:
One patient who was given two sittings of SCT made very good improvement and is now ambulant with the aid of an Orthosis. Two other patients who received one sitting of SCT had objective sensory and mild motor improvement; Three other patients had no improvement. There were no adverse reactions in any of them.
Conclusion:
SCT is an evolving option for Spinal Cord Injury patients and although it is too early to (Coffey et al) . In this study we report our research work on different approaches to the above diseases using cell therapeutics.
Study 1 Materials & methods:
Ciliary Pigment Epithelium was harvested from donor eyes from Aditya Jyot Eye Hospital, Mumbai and was taken to and grown at NCRM lab. The cells were grown in the earlier reported methodology of Brenda et al (Science 2004) .
Results:
The CPE derived Retinal stem cells grew well in the lab. However, the practical difficulties of harvesting the same in patients limited our further steps in this study.
Study II
Materials & methods:
Cadaver eye RPE cells were harvested and grown using polymer scaffolds after transporting them over 6 to 12 Hrs. The RPEs were grown on conventional methods and in polymer scaffolds and were subjected to RT-PCR.
Results:
Human RPEs were able to grow without amniotic membrane and the same was proven by RT-PCR. This would make it possible for the peripheral RPEs taken from patients to be stored and later expanded and used for replacing the diseased cells of the central portion of the retina in future, without having to harvest the RPEs again.
Study III
Materials & methods:
Bone marrow mono nuclear cells were isolated and transported in cold containers (4-8oC) over a period of 6-12 Hrs and viability was evaluated.
Results:
The bone marrow mononuclear cells were viable up to 12 Hrs in our methodology with a viability of more than 95% making it possible for cells isolated from Chennai centre to be taken to Mumbai or any other destination within a reach of 12 Hrs for application as reported in earlier studies.
Conclusion:
The in-vitro expansion of RPEs without Human Amniotic Membrane is expected to open up a new possibility for treating the Retinal Degenerative Diseases. However an animal study is needed before clinical application. Intra vitreal application of Bone Marrow Mono Nuclear cells to treat RP and AMD as reported earlier are considered safe. We plan to undertake treatment and long term follow-up of more numbers of patients with RP and AMD.
hospitals. Studies comparing presently available scaffolds with novel nanomaterials for the application of CES into the affected portion of the eye will be undertaken. Long term cryopreservation and transportation to and fro from longer distances will be standardized to enlarge the network.
Expected Outcome:
Ninety thousand patients are in the backlog every year, waiting for corneal transplantation in India, of which 30,000 may benefit from CESBANK. The CESBANK, as per the present plan, would be able to provide expanded CES for at least 14000 eyes to be treated every year when fully functional, provided it gets adequate number of donor eyes.
Conclusion:
The present project when implemented could make one donor eye be usable to more than 5 to 14 recipient eyes. By increasing the awareness for eye donation, more patients with corneal endothelial diseases awaiting donor cornea could be treated.
